DataMeds AI, Inc. said Corexa Pharmacy generated more than $1 million in preliminary, unaudited revenue in September 2026, more than 66% above July 2026. The company has not disclosed the July dollar figure, a revenue breakdown, or Corexa-specific profit or margin results, so the announcement is an early monthly update—not a finalized or audited financial result.
How much revenue did Corexa Pharmacy report?
In an October 1, 2026 company announcement, DataMeds AI (NASDAQ: MEDS) reported that Corexa Pharmacy had more than $1 million in preliminary, unaudited revenue for September 2026. DataMeds also said September revenue was more than 66% higher than in July 2026. The company did not state July’s dollar amount in the release, and the September figure may change.
These are company-reported monthly figures. The announcement does not provide an audited Corexa segment result or a breakdown of revenue by product or service. It also does not report Corexa-specific profit or margins. Readers should not treat the revenue figure as earnings, cash flow, or a finalized result. DataMeds AI’s announcement
What does the company say drove growth?
DataMeds attributed the increase to a growing retail customer base, more prescriptions filled, and launches of Tollo Health proprietary dietary supplements and medical foods. The release does not quantify how much revenue came from any of those factors. They are management’s explanation, not a separately measured driver-by-driver account.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →#1 Best Overall
Gerald Commissiong, identified in the release as DataMEDS’ Interim Co-CEO, said: “Having completed the rebranding of Corexa Pharmacy in the first month of the third quarter of 2026, we are very pleased to already see such substantial growth so quickly,” The company’s announcement also cautions that expectations about continued growth and future demand are forward-looking statements; actual results may differ materially.
How Corexa fits into DataMeds’ business
DataMeds describes Corexa Pharmacy as a division of its wholly owned subsidiary Corexa Health. Corexa Health provides pharmacy dispensing and related services, including distribution of selected Tollo Health products under a wholesale distribution arrangement.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
The company says its Health Lives Here mobile application offers Corexa Pharmacy as a fulfillment option for telehealth prescriptions. It also said Corexa’s physical location was being upgraded as a flagship model for a network it describes as comprising more than 6,500 independent pharmacies. Those are company-reported channel and expansion plans; the announcement does not establish that the network rollout will occur or quantify any financial effect.
What the revenue announcement does—and does not—show
- It shows: DataMeds reported September 2026 Corexa Pharmacy revenue above $1 million on a preliminary, unaudited basis, and said the figure was more than 66% above July.
- It does not show: finalized or audited monthly revenue, the July revenue amount, revenue by prescription dispensing versus adjunct products, or Corexa-specific profitability.
- It does not establish: that the cited growth drivers contributed equally, that growth will continue, or that the company’s pharmacy-network plans will deliver revenue.
What products are mentioned?
DataMeds identifies Tollo Health supplements and medical foods as part of Corexa’s reported activity. The company’s media room lists Tollovid as a dietary supplement and Galectovid and Forzet as medical foods. Their mention in a revenue announcement is commercial context, not evidence of health benefits or an endorsement of medical use. DataMeds AI media room
Quick Recap
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
